Diphenylhydantoin and lidocaine modification of A-V conduction in halothane-anesthetized dogs.
The effect of halothane on A-V conduction was evaluated in gods during atrial pacing using the  technique of His-bundle electrocardiography. In addition, the effects of lidocaine and diphenylkydantoin (DPH) on A-V conuction were examined during halothane anesthesia. Effects of these drugs  on three subintervals of A-V conduction were compared. These included the -H (stimulus atifact of His-bundle deflection-atrioventricular conduction), H-Q (His-budnle deflection onset of QRS complex-His-Purkinje conduction), and H-S intervals(His-bundle delfection to end of QRS COmplex-total intraventricular  conduction). Linear regression best described the relationship between duration of interval (P-H, H-V,and H-S) and heart rate during incremental increases in the atrial paced rate. Data from these experiments were fitted to a multiple lenear regression model that predicted the effect of increasing concentrations of halothan, lidocaine, and DPH  on slope and intercept coefficients. In creasing concentrations of halothan ( 30 and 45 mg/100 ml arterial). Both lidocaine and DPH further depressed conduction at all levels of halothan anesthesia. The P-H interval was particularly sensitive todrug effefts. This may represent potentiation of the normal slowing of conduction through the AVnode in response to incremental increases in heart rate (fatigue response.) We conclude thatboth lidocaine and DPH fail to reverse the depressant effect of halothane on A-V conduction. This may explain their ineffectiveness in treating certain types of arrhythmias during halothane anesthesia.
D000769:Anesthesia, Inhalation; D000818:Animals; D002036:Bundle of His / Q000187:drug effects; D006328:Cardiac Catheterization; D003864:Depression, Chemical; D004285:Dogs; D004562:Electrocardiography; D006221:Halothane / Q000008:administration & dosage / Q000494:pharmacology*; D006325:Heart Atria / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D008012:Lidocaine / Q000494:pharmacology*; D010138:Pacemaker, Artificial; D010672:Phenytoin / Q000494:pharmacology*; D011690:Purkinje Fibers / Q000187:drug effects
D010672:Phenytoin; D008012:Lidocaine; D006221:Halothane